| Severe capecitabine toxicity associated with a rare DPYD variant identified through whole-genome sequencing RC Ly, RE Schmidt, PJ Kiel, VM Pratt, BP Schneider, M Radovich, ... JCO Precision Oncology 4, 2020 | 14 | 2020 |
| An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes S Ghaffari, C Hanson, RE Schmidt, KJ Bouchonville, SM Offer, S Sinha Genome biology 22, 1-28, 2021 | 13 | 2021 |
| Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD) T Zhang, A Ambrodji, H Huang, KJ Bouchonville, AS Etheridge, ... Elife 13, RP94075, 2024 | 1 | 2024 |
| BEDwARS: a robust Bayesian approach to bulk gene expression deconvolution with noisy reference signatures S Ghaffari, KJ Bouchonville, E Saleh, RE Schmidt, SM Offer, S Sinha Genome Biology 24, 178, 2023 | 1 | 2023 |
| Minnesota: A Poetic Exploration of 72 Creatures Big and Small R Schmidt | | 2023 |
| A Robust Bayesian Approach to Bulk Gene Expression Deconvolution with Noisy Reference Signatures S Ghaffari, KJ Bouchonville, E Saleh, RE Schmidt, SM Offer, S Sinha bioRxiv, 2022.10. 25.513800, 2022 | | 2022 |
| DPYD enhancer variant confers increased risk of severe toxicity in 5-FU chemotherapy T Zhang, A Ambrodji, H Huang, K Bouchonville, A Etheridge, R Schmidt, ... Cancer Research 82 (12_Supplement), 5420-5420, 2022 | | 2022 |
| Novel approach to thymidylate synthase genotype determination and utility as a biomarker of severe toxicity to 5-FU chemotherapy H Huang, D Schaerer, R Schmidt, T Zhang, TK Froehlich, K Bouchonville, ... Cancer Research 82 (12_Supplement), 5805-5805, 2022 | | 2022 |
| REGULATORY VARIANT IN NOVEL DPYD ENHANCER REGION AS A POTENTIAL RISK MARKER FOR 5-FLUOROURACIL (5-FU) TOXICITY. JC Nunez, T Zhang, R Schmidt, H Huang, K Bouchonville, A Etheridge, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S11-S11, 2022 | | 2022 |
| Satori 2018 EL Cavanaugh, W Larson, E Leith, S Wakeham, R Williams-Belter, ... Winona State University, 2018 | | 2018 |
Robert B. DiasioMayo Clinic Cancer CenterVerified email at mayo.edu
